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SUMMARY
The goal of this research is to evaluate the secondary prompt gamma (PG) yield from
proton therapy at high characteristic energies from MC model simulations and experimental
data. Recent studies indicate that target composition influences PG characteristic energy
and yield, and the quantification of PG may be used to offer real-time dose verification for
proton therapy. In this study PG analysis was performed for MC simulations to evaluate the
characteristic measurements and total yield of secondary PG emitted from a target in the
0-8 MeV range from a proton therapy beam over a range of four different beam energies (70
MeV, 160 MeV, 200 MeV, 220 MeV). This was repeated in several target materials (carbon,
calcium oxide, calcium fluoride, PMMA, and HDPE) in order to evaluate the influence of
the incident energy and the target material on the PG yield and energy spectra. PG energy
spectra determined from the specified target materials indicated that the 3.74 MeV energy
peak shows a linear correlation between PG intensity and calcium mass fraction of the target
material. 6.13 MeV and 4.44 MeV energy peak are not unique to the respective, oxygen
and combined oxygen and carbon, mass fraction of the target material. This relationship is
complicated by the addition of calcium within the target. Experimental data was collected
in order to validate the computational model based on comparison of relative characteristic
energy peek intensities. The relative peak ratio determined from experimental data is in





The overarching goal of any external beam radiation treatment therapy is to administer
a uniform dose to precisely targeted tissue while minimizing dose to healthy tissue and to
organs at risk (OAR). Any recent and future improvements in accuracy and dose delivery
generally come from improved contouring of the target region [12]. Traditionally, high-
energy photon and electron beams have been the predominant sources used for medical
ionizing radiation treatment applications due to their well characterized gradual dose fall
off. However, the depth dose curves for both of these particle types peak at or near the
surface of the exposed tissue, limiting their effectiveness for treating tissue deeper within
the patient, as seen in Fig. 1. Recent advances in technology have created renewed interest
in proton therapy for medical applications.
While knowledge of the potential advantages for proton therapy due to the unique
interaction characteristics of protons has been available for several decades, it has not been
capitalized on in clinical applications primarily due to the large capital expense, the particle
range uncertainty, and long reconstruction computing times [12]. Dedicated multi-room
treatment facilities and continued advancements in computing power have allowed us to
work through the capital expense and computing time limitations. As a result, this has
created a renewed interest and need for improved range verification in order to improve
treatment planning and dosimetry for proton therapy. There are currently a variety of
methods of proton range verification being investigated, including direct measurements,
calculations based on indirect measurements, as well as improved reconstruction algorithms
[12].
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Figure 1: Depth Dose Curve: comparison of the depth dose profiles for various particle
beams, (a) 4 MeV electron beam (b) 4 MeV photon beam, (c) 20 MeV photon beam and
(d) 150 MeV proton beam.[8]
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Table 1: Research Questions.
1. What is the absolute yield of secondary PG from a proton beam at clinically
relevant energies of 70, 160, 200, and 220?
2. Can target material or the RSP be determined based on the absolute yield of the
secondary PG from a proton beam?
3. Can location specific energy spectra of the secondary PG from a proton beam be
used to determine target material or the RSP along the proton path?
1.2 Objective
This research will evaluate the secondary prompt gamma (PG) yield resulting from target
interactions with proton beams at high characteristic energies used in proton therapy based
on Monte Carlo (MC) model simulations. Recent studies indicate that target composition
influences PG characteristic energy and yield, and the quantification of PG may be used
to offer real-time dose and range verification for proton therapy. To evaluate this, a com-
putational model was developed to generate the predicted secondary PGs resulting from
proton beam interactions at four clinically relevant energies (70 MeV, 160 MeV, 200 MeV,
and 220 MeV), in several target materials (carbon, calcium fluorine, calcium oxide, PMMA,
and HDPE) are compared in order to evaluate the influence of the incident energy and the
target material on the PG energy spectra. The total yield of secondary PGs emitted and
the characteristic energy PGs released from interactions of a proton therapy beam with a
target are determined and evaluated for correlations with range and material composition,
respectively.
In order to benchmark our MCNP simulation results, experimental measurements of
the PG emitted from a target composed of carbon, oxygen and hydrogen are taken and the
resulting PG energy spectra ratios are compared to those produced by the MCNP simula-
tions. Specifically, the experimental data collected from Chicago Proton Center (CPC) is
analyzed to evaluate the location specific, characteristic energy spectra for each of the tar-
gets. These results are then compared with the respective results generated by the MCNP
code package. Finally the uncertainty of the calculations are evaluated.
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1.3 Current Technologies and Methods in Proton Therapy
1.3.1 Proton Therapy: Method
Proton therapy uses heavy charged particles to irradiate unhealthy tissue. Recently, this
method has gained popularity as it looks to take advantage of the lower integral dose to
the patient, the well-defined range, and sharp dose fall-off characteristic of heavy charged
particle interactions, as shown in Fig. 1 by the proton curve. In contrast to photon and
electron beams, proton beams deliver a relatively constant and minimal dose to the surface
and superficial tissue, depositing the majority of their dose near the incident particles
end of range. The velocity of the proton particle is much higher near the surface of the
target object than in the deeper regions. Based on the Bethe-Bloch formula, which will
be discussed further on, the energy deposited per unit length is inversely proportional to
the square of the particle velocity. Thus the proton particles deposit most of the dose in
the Bragg peak region just before reaching their end of range [21]. Relatively no dose is
distributed to tissue beyond the peak depth or distal-edge of the Bragg peak, allowing the
Bragg peak to be placed directly over a target region by adjusting the energy of the incident
proton beam. Because the Bragg peak is most often smaller than the tumor or treatment
region, what is known as a spread-out Bragg peak (SOBP) is used. While this is executed
in various ways it is effectively the delivery of a series of incident beam energies in various
time increments in order to cover the area of interest as displayed in Fig. 2.
An ideal proton treatment plan would align the Bragg peak with the target tissue, and
the distal-edge of the Bragg peak could be placed immediately in front of healthy tissue or
OAR, as described in the top image of Fig. 3. Unfortunately, this is not current practice
due to the range uncertainty and the dramatic change in delivered dose resulting from
minimal changes to proton range, as depicted by the lower images in Fig. 3. Uncertainties
in the exact position of the Bragg peak result from a combination of organ motion, setup
and anatomical variations, dose calculation approximations and biological considerations
[20]. Accurate proton treatment planning requires the use of the tissues relative stopping
power (RSP), which is the mean energy loss of protons per unit path length of the material
4
Figure 2: Spread out Bragg peak: The SOBP is the summation of a series of individual
Bragg peaks generated over various energies [15].
Figure 3: This image depicts the dose delivery benefits of proton irradiation relative to
photon irradiation. It also highlights the increased importance of range accuracy from
proton treatment due to the abrupt changes to delivered dose that occur with minute
changes in range. Image as seen in [12].
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relative to that of water. This is because the proton interactions are dependent on Coulomb
interactions in addition to being affected by the chemical composition of the materials and
their electron density.
1.3.2 Proton Therapy: Imaging
Treatment planning, patient setup, and anatomical localization for proton therapy depend
on some form of imaging to provide various pieces of patient specific data. One of the notable
limitations of proton beam planning is the range uncertainty of approximately 1-2%, which
is particularly significant for proton treatments since small variations dramatically alter
deposited dose to tissue regions at the distal end of the range. This can be visualized by
comparing the change in delivered dose due to a shift in range for photons versus protons
as shown in the lower three images of Fig. 3.
1.3.2.1 Current Imaging Method
The currently accepted method for proton treatment planning is very similar to that of
photon therapy. A photon computer tomography (CT) of the patient is obtained to pro-
vide patient specific anatomical localization and the tissues photon attenuation information.
This is determined from the images based on Hounsfield Unit (HU) values, which are a mea-
sure of the tissues contrast relative to that of water. The HU values are then converted to
RSP, and the tumor(s) and OAR are contoured on the collected images. This information
is then used to determine the treatment factors such as the beam configurations, the aper-
ture and compensators, and the beam weightings, satisfying a specific set of dose-volume
constraints. Next the output factor measurements for each field are taken as a quality as-
surance step. Then, on the day of treatment delivery, patient setup is verified with x-ray
image guidance, and dose is delivered. There is currently no direct range verification or
feedback loop as used with photon and electron therapy due to their relatively linear fall
off or exit dose.
The limited accuracy due to x-ray CT treatment planning for proton therapy is, in part,
due to differences in the interactions of x-rays and heavy charged particles. HU values are
based on photon attenuation, which is dependent on electron density. In contrast RSP
6
values depend on the chemical composition of the tissue(s) and Coulomb interactions. In
order to convert the HU values to RSP, a conversion factor is determined based either on
empirical data collected from the simulation CT scanner for various tissues or according to
a stoichiometric calibration method designed to reduce the error due to nonhuman tissue
phantoms [30]. This calibration curve is determined based on theoretical HU values and
RSPs determined from assumed atomic compositions of tissues determined by experimental
measurements on tissue equivalent materials. This is currently the most predominantly
used method [30].
The HU values are not unique for each RSP because these two values are describing two
corresponding but different physical properties [30]. In addition, HU values are affected
by beam hardening and tissue location in the beam whereas RSP values are not. This
conversion step can contribute to the overall range uncertainty (up to 2%) [12]. Ultimately,
any method of determining RSP from HU numbers is handicapped due to the degeneracy in
correlation between HU and RSP of various materials. The removal or a reduced dependency
on this conversion factor could improve treatment accuracy by reducing range uncertainty.
1.3.2.2 Current Experimental Imaging Method
There are currently a variety of methods of proton range verification being investigated.
These include both direct measurements, such as point dose, range probe, and proton ra-
diography/tomography; calculations based on indirect measurements, such as PG imaging,
positron emission tomography (PET) imaging, magnetic resonance imaging (MRI) imaging,
and hybrid imaging systems as well as improved reconstruction algorithms [12]. A closer
review of several of these methods will be described in the following sections.
One method for reducing the proton range uncertainty is to remove the conversion
from HU value to RSP [22]. The RSP could be determined directly by generating images
with a proton source, such as with proton computer tomography (pCT). During a pCT
scan a low intensity beam of high-energy protons is used to generate radiographic (2D) or
tomographic (3D) images. As protons travel though matter they lose energy though inelastic
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collisions, resulting in ionizations and excitations, and elastic collisions that result in small-
angle deflections of the incident protons called Multiple Coulomb Scattering (MCS). Due to
the relatively large number of interactions that take place over the path-length, significant
deviation from the protons original direction is observed. As these interactions take place at
random, a statistical distribution results in both the amount of energy lost by the incident
particle per interaction and the lateral and angular change from the incident direction [27].
Because of the MCS, it is not possible to track the trajectory and path length of the proton
directly, but there are several methods suggested to reconstruct the particle’s path.
A pCT imaging device is composed of (a) two parallel tracking plates, in front of and
behind the object, that measure the entrance and exit position (location) and direction
(angle) of the particles and (b) a calorimeter which measures the exit energy. Fig. 4 de-
picts a current proton CT system [7]. This proton transmission information allows for the
reconstruction of the energy loss of the incident proton or the density distribution of the
traversed tissue leading to the calculation of the averaged RSP of the track length. This
information can be used directly as input for proton radiotherapy treatment planning [26].
According to Schulte [27], the use of pCT could reduce proton therapy range uncertainty
due to the relative electron densities of the tissues. Further, it could remove the uncertainty
from the acquisition of HU values and the inaccuracies due to artifacts with proton doses
comparable to those of x-ray or cone beam CT.
Another method of reducing uncertainty currently being investigated is indirect proton
range measurement which can be determined through the detection of the resulting gamma-
rays. The two methods currently under investigation are PET imaging and PG detection.
PET imaging, which is the detection of coincident gammas from positron annihilation, can
be used to detect the positrons emitted from the isotopes resulting from proton nuclear
interactions. Limitations of this method are due to the fact that induced activity is depen-
dent on tissue composition. Calculations are further complicated by activation threshold
energies. PET imaging uses gamma cameras to detect photons from pair annihilation of
a positron and an electron at the fixed energy of 511 keV with energy collimation. In the
case of proton therapy, the positron emitters are produced by nuclear reactions that result
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Figure 4: pCT imaging device is composed of (a) two parallel tracking plates, in front of
and behind the object, that measure the entrance and exit position (location) and direction
(angle) of the particles and (b) a calorimeter which measures the exit energy. Image as seen
in [22].
from inelastic collisions between the incident proton and target nucleus [26].In this case the
detected annihilation photons produced in the patient can be used to indicate the location
of the proton beam within the patient and relate this to their anatomy [29]. The appli-
cation of PET for real-time monitor is difficult because the decay time of PET isotopes
is significantly longer relative to PG emission time and it is not an effective use of clini-
cal therapy treatment rooms [10]. Unfortunately, there is a divergent relationship between
the induced activity distribution and the dose distribution due to the dependence on the
elemental composition [12].
PGs are the result of nuclei excitation along the proton path. These interactions, which
release the PG, with an energy range of 2-15 MeV, occur along the whole of the proton
path, stopping a few millimeters before the Bragg peak, approximately within 2-3 mm [12].
This fall off is the result of the drop in reaction cross section due to the decreasing energy
of the incident particle [12]. “After an interaction, the target nucleus is excited to a higher
energy state and then emits a single photon (prompt gammas) to return to its ground
state.” [12] While it is important to note that the falloff in PG emission is not equal to
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Figure 5: Compares the intensity distribution of (A) annihilation gamma-rays and (B) PGs
(shown as solid black line) with the energy deposited by a proton beam (shown in by solid
blue line) along the depth of a simulated target in millimeters. Image as seen in [10].
the dose falloff, this method allows real time dose delivery verification. However, clinical
application requires enhanced detectors for gamma detection in this energy range because
these energies are often too high to be fully deposited in the detector region. “Interestingly,
for the latter method [PG], the maximum in the cross section as a function of energy is
at lower energies compared to the PET isotope production cross sections. This causes the
depth position of the maximum in the photon signal to be closer to the Bragg peak than in
the case of the PET imaging method [19]. [See Fig. 5.] Another advantage compared to the
PET method is a potentially higher count rate.” [20]. As a proton therapy plan is typically
delivered at a 2 Gy/min dose rate which yields a proton flux on the order of 5 ∗ 109/cm2/g,
the resulting inelastic emission rate per volume is the product of the flux, cross-section, and




2.1 Basic Proton Physics in Matter
In order to improve the accuracy of any dose delivery it is useful to have a working knowledge
of the proton interaction behavior in matter. Protons are heavy charged particles. They
interact with matter through both elastic and inelastic interactions. These interactions
result in stopping, scattering, and nuclear reactions.
2.1.1 Stopping
As the protons move though material, they continually lose kinetic energy through interac-
tions with the orbital electrons of the medium until they eventually come to a stop within
the medium. This empirical process is best described by the Bethe-Block theory of stop-
ping power, which was developed to describe slowing down and stopping behavior of heavy
charged particles, such as protons, as they interact with matter. According to Attix [2],
stopping power is the expectation value of the rate of energy loss per unit path length
by a particular charged particle of a specific energy in a medium. It is dependent on the
initial energy of the particle and the electron density and mean ionization energy of the
medium. The incident particle transfers increasing amounts of its kinetic energy as it slows
down along the track length, ultimately depositing the majority of its energy near its end
of range. For clinical applications the Bethe-Bloch formula can be represented as follows:
−dE
dx
(r) = ηe(r)S(I(r), E(r)) (1)
“where ηe is the relative electron density with respect to water, I(r) is the mean excitation
potential of the material, which for water is 75 eV, E(r) the proton energy, and S is the
proton stopping power in water, which can be expressed as [depicted in Eq. 2 ]”











“The constant K is often assumed to be 170 MeV/cm and combines various physical
parameters, me is the electron mass and is the proton velocity relative to the speed of
light. The dependence on the position vector r is a reminder that all quantities in [the
stopping power equation] can vary with spatial position in the object.” [27] “For tissues,
the uncertainty in I-value is potentially on the order of 10 -15% (Andreo 2009). This might
result in a range uncertainty in tissue of 1.5%”, see Fig. 3 [20].
2.1.2 Scattering
The predominant reaction type is elastic interactions resulting in scattering reactions also
known as MCS. In these reactions the incident proton collides with orbital electrons of the
medium and transfers a portion of the protons kinetic energy to the electron. This results
in the electron being excited or ejected from its orbital and the proton being redirected at
a slight angle with an overall forward projection and a slightly lower kinetic energy.
2.1.3 Nuclear Reactions
In addition to the stopping and MCS that results from interactions with orbital electrons,
incident protons can also undergo nuclear reactions which are inelastic collisions that in-
teract with and excite the atomic nuclei resulting in an unstable atom. These interactions
result in the generation of secondary particles including gamma-rays, neutrons, protons
and, more rarely, alpha particles as the atom works to return to a stable configuration.
This type of interaction takes place about 15-20% of the time depending on the energy of
the particle. These reactions result in the knock off of a nucleon that re-stabilizes through
positron emission or excitation which return to ground state by releasing PGs.
PGs are the result of nuclear reactions that result in nuclei excitation along the proton
path. These characteristic prompt gammas are released with an energy range of 2-15 MeV
depending on the atom from which they were generated. Production of PGs stop several
millimeters before the Bragg peak due to the incident particles reduced kinetic energy.
Detection and quantification of these PGs allows real time dose delivery verification [12].
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2.2 Secondary Measurements: Prompt Gammas
Evaluation of the prompt gamma-rays resulting from proton beam interaction with a target
has the potential to not only provide improved online range verification to within 1-2 mm
accuracy but also provide additional useful information regarding elemental tissue compo-
sition based on the analysis of the PG energy spectra. In addition to range verification, the
emitted PG spectrum can be used to determine the elemental composition of tissue along
the tack length [24]. According to Yang [30], the most significant factor affecting over-
all RSP uncertainty is the variations in tissue composition, especially in soft tissue, since
it is the dominant tissue type in patients. This suggests the importance of determining
the patient specific tissue composition in order to reduce its impact on the overall uncer-
tainties in proton RSP estimation [30]. Yang [30] found “that the key tissue composition
factors were the mass density and the percentages of hydrogen (H) and calcium (Ca).” [30]
“The emission spectrum is in the range of MeV... The most prominent lines are 511 keV
(positron annihilation), 2.2 MeV (deuterium), 4.4 MeV (carbon) and 6.1 MeV (oxygen).”
[13] The relative intensity ratios of the peaks of interest could provide additional informa-
tion for improved RSP calculations as well as “a method for analyzing changes in the tissue
composition in vivo during irradiation, or from treatment fraction to treatment fraction.”
[12]
Proton interactions result in inelastic nuclear reactions that produce gamma rays ap-
proximately 15-20 percent of the time for intermediate incident energy ranges (reaction rate
approximately 20% at 160MeV [14]). This can result in either PG emitting from excited
target nuclei or coincident gammas emitting from positron emission isotopes [[17],[12]]. Co-
incident detection of gamma-rays would apply PET, thus require longer count acquisition
times due to low efficiency and require off-line detection. In contrast, PGs are emitted very
quickly after the initial inelastic nuclear reaction, within 10-19-10-9 sec, and the lack of co-
incident collimation permits increased acquisition efficiency, which allows for real-time/live
detection [14]. These PGs are emitted at characteristic energy levels, in the MeV range (2-15
MeV), that are unique to the specific atomic nucleus from which they are released. Thus,
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the resulting energy spectra can be analyzed to provide additional localized information
regarding the atomic fractions of the material the proton travels through. Capturing and
incorporating this information would allow for improved treatment planning and monitoring
without additional dose delivered to patient [12].
2.3 Prompt Gamma Detection Method
PGs are emitted along the entire proton path up “until 2-3 mm [anterior] to the Bragg-
peak”, allowing for range verification of the dose deposition in the target material [12]. The
resulting spectra are relatively noisy particularly at the tail due to scatter, bremsstrahlung
and neutron contamination. In order to understand the challenges associated with detecting
PG it is useful to have a general understanding of types of interactions gamma-rays may
undergo.
2.3.1 Gamma-ray Interaction
Gamma-rays are packets of energy or photons released from the nucleus of an atom. They
can interact with matter in three ways, though photoelectric absorption, Compton scatter,
or pair production. The probability of the type of interaction that takes place is governed
by the energy of the photon and the atomic number, or Z of the material, with which it
interacts. Photoelectric absorption dominates in high Z materials at low energies. As the
energy of the gamma increases Compton scatter effect becomes more predominant for all Z
materials until roughly 10 MeV. Around this energy pair production takes over for high Z
material.
2.3.1.1 Photoelectric Absorption
Photoelectric effect describes the phenomenon in which a gamma-ray interacts with an
electron that is tightly bound to an atom. The incident energy of the gamma-ray, λ, must
be greater than or equal to the binding energy, Eb, of the electron. During the interaction
the gamma-ray disappears and results in the release of a photonelectron from one of the
electron shells. The kinetic energy of the photoelectron, Epe, is described by Eq. 3. The
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Figure 6: Diagram depicting Compton scattering effect in which the incident gamma-ray,
λ, interacts with a free electron. This interaction results in a recoil electron and a scattered
photon, λ′, which share the energy of incident gamma-ray. Source [9].
binding energy is also released by an Auger electron or as a characteristic X-ray and the
vacancy created in the electron shell is filled by rearranging the remaining electrons.
Epe = λ− Eb (3)
2.3.1.2 Compton Scatter
Compton scatter effect describes an elastic collision in which the incident gamma-ray in-
teracts with a free electron. A free electron describes an electron with a binding energy
significantly less than the energy of the incident gamma-ray. This interaction results in a
recoil electron and a scattered photon which share the energy of incident gamma-ray as
shown in Fig. 6 and described by Eq. 4.






As dictated by Eq. 4 there are two limiting cases, when Θ equals 0 or 180 degrees.
When Θ equals 0, none of the incident energy is transferred to the electron and the photon
continues in the incident direction. However, when Θ equals 180 degrees the maximum
amount of energy is transferred to the electron as the gamma-ray is back-scattered. Since all
scattering angles can occur, a Compton continuum is observed. The energy of the scattered
photon can be determined from Eq. 5. Doppler broadening, due to “finite momentum of
orbital electrons, also cause the gamma-rays that are scattered at a fixed angle from” the
source to have a narrow energy distribution rather than a single energy as theoretically







Pair production is an inelastic reaction that takes place as an incident gamma-ray, with
an incident energy greater than 1.02 MeV, passes though an intense electric field near a
nucleus (or electron, though with significantly less probability and a higher threshold energy
of 4m0c
2). The gamma-ray may spontaneously convert into an electron and a positron, with
a combined kinetic energy roughly equal to the incident energy less 2m0c
2, roughly 1.02
MeV, as seen in Eq. 6.
Ee− + Ee+ = λ− 2m0c2 (6)
Since the positron is not stable, once it comes into contact with one of the surrounding
electrons it will annihilate, releasing two 511 keV photons. This reaction takes place very
quickly and near the initial reaction and thus is perceived to be in coincidence with the
initial pair production reaction. For detection purposes, if one or both on the annihilation
photons escapes the detector, a peak equal to the incident energy less 0.511 MeV or 1.02
MeV respectively will be observed.
2.3.2 Detectors
Any detector used for this application would need to be able to completely absorb the
energy of the incident PG. This is particularly challenging for this application as the energy
range of the particles of interest which are between 2-7 MeV, much higher than sweet spot
of equipment currently on the market for clinical applications. Much current research is
being focused on the effort to build a detector that is optimized for this energy range.
2.3.2.1 Collimated Prompt Gamma Camera
The gamma camera is the same as that used with single-photon emission computed to-
mography (SPECT) imaging but with improved detectors capable of capturing high energy
gamma rays with high resolution energy and efficiency. “In early setups [the collimated
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prompt gamma camera] approach was challenged by neutron background radiation and
stray gammas, necessitating thick layers of collimation. [MC] simulations imply, however,
that array-type setups would allow for the measurement of prompt gamma distributions
from therapeutic proton beams” [18]. On the other hand, a recent publication by Bom et
al. [4] claims that challenges could be solved by using a gamma camera in combination with
a knife-edge shaped slit placed perpendicular to the beam direction. It has also been shown
by Biegun et al. [3] and J. Polf [24] that this can be cleaned up by incorporating neutron
suppression through time-of-flight (TOF) techniques or Compton suppression. TOF tech-
niques can be used to flag PG that are emitted within a specified time window relative to
the release on the incident beam particles. “Compton suppression uses guarded detector
to measure the scattered Compton background, which can be subtracted from the primary
detector. In MC simulations they show that under common therapy conditions for proton
spot scanning, enough data during one spot can be collected to enable identification of the
location of the distal dose edge with a 1 sigma accuracy of better than 1 mm.” [12] A




3.1 Monte Carlo: MCNP
Los Alamos National Laboratory (LANL) maintains and updates a MC nuclear transport
code commonly referred to as MCNP. It is a software package that was designed to simulate
nuclear processes [16]. The most recent version, MCNP6, is an update that merges the
capabilities of MCNP5 and MCNPX. MCNPX (MCNP extended) was developed to track
a larger range of particle types and heavy ions over a wider range of energies making it
particularly useful for medical physics studies. The new version “has been expanded to
handle a multitude of particles and to include model physics options for energies above the
cross-section table range, a material burnup feature, and delayed particle production.” [16]
It also provides “[e]xpanded and/or new tally, source, and variance-reduction options.” [16]
3.2 Preliminary MC Simulation of PG Generation
In the preliminary simulations MCNP6 was used to simulate PG emission spectra generated
from proton induced nuclear reactions in medium of varying composition of carbon, oxygen,
calcium, and nitrogen, the predominant elements found in human tissue. The relative peak
intensities at discrete energies predicted by MCNP6 were compared to the corresponding
atomic composition of the medium.
Figure 7: Simulation Phantom: cylindrical phantom (5cm x 2cm (r=1cm)) made up of five
1 cm homogeneous subsections.
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Figure 8: Cross-section of cylindrical phantom (5cm x 2cm (r=1cm)), in red. Black tracks
indicate a binary representation of the interaction track of incident proton particles as they
move through air and the target material. This neglects the relative intensity of tracks,
which, if depicted, would show a greater concentration of tracks tightly packed in the
center.
In this simulation model, the incident proton particles are targeted on a cylindrical
phantom (5cm x 2cm (r=1cm)) made up of five 1 cm homogeneous subsections, see Fig. 7.
The source is 10 cm away from the surface of the target. Both the source and phantom
are staged in a “room” (12 x 14 x 9 ft3) filled with air. This MCNP6 model is tracking
the interactions resulting from a mono-energetic proton source that released 106 particles
at 40 MeV from a disk source, 1 cm radius, uni-directionally in the +z direction. Fig. 8
graphically displays the proton particle tracks as they enter and move through the target.
This model neglects any energy straggle or degradation of the 40 MeV protons due to
generation or interaction with the beam nozzle as they are released and any interactions
structural or stabilization equipment (e.g. couch) that would potentially interfere.
As output, energy spectra are generated from the PGs that originate from within and
escape the specified cell of interest of the phantom: the solid green cell depicted in the
phantom, Fig. 7. Fig. 8 shows a cross-section of cylindrical phantom. The black tracks
indicate a binary representation of the interaction track of incident proton particles as they
move through air and the target material. This neglects the relative intensity of tracks,
which would show a greater concentration of tracks tightly packed in the center. The
results show a good general agreement with experimentally measured values reported by
other investigators using MCNPX [23]. However, unexpected divergence from experimental
spectra was noted in the peak intensities for some cases depending on the source of the
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cross-section data when using compiled proton table libraries versus physics models built
into MCNP6. While the use of proton cross-section libraries is generally recommended when
available, these libraries lack data for several less abundant isotopes. This limits the range
of their applicability and forces the simulations to rely on physics models for reactions with
natural atomic compositions.
3.2.1 MCNP6 Model Limitations
In MCNP6, different cross section libraries are used for the particle-production data cor-
responding to how the material data cards are coded. When the material is coded as
elemental calcium (020000) the particle-production data for protons being used is from
20000.62c library. When the target material is coded as specific calcium isotopes (020AAA)
the particle-production data for protons being used is the corresponding 20AAA.80c library.
The tabulated neutron and photon creation counts and the PG spectra that result from
the two different data libraries are not in agreement. In this case the continuous energy
cross-section libraries used as input for our MC simulation are based on evaluated nuclear
data files or ENDF/B-VI Release 3 evaluated nuclear data library. This was chosen due to
the fact that it is the only one cross section library available containing any tabular data
for proton interactions, currently including 48 isotopes.
3.3 MCNP MC Simulation
In the next set of MC simulations the target materials (carbon, calcium oxide, calcium florid,
PMMA, and HDPE) are modeled with various mono-energetic incident proton beams (70,
160, 200, 220 MeV). The target material cards are modeled based on the elemental mass
fraction as shown in Tab. 2. These MCNP models are used to determine (a) the PG energy
spectra from each target and energy combination and (b) the proton range within the target.
The PG energy was generated by running a MC simulation software package, MCNP6. The
range data was then be compared with the projected proton range determined by CSDA
Range, Pstar, and SRIM [31]. The PG yield and the PG relative peak intensities at discrete
energies predicted by the MCNP code is compared to similar data previously published and
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Table 2: Composition mass percent.
Target Density H C N O Ca F Ar
(g/cm3) (%) (%) (%) (%) (%) (%) (%)
PMMA 1.18 8.05 59.99 31.96
Calcium fluoride 3.18 12 51.3 48.67
Calcium oxide 3.35 28.53 71.47
Carbon 2.25 100
HDPE 0.94 14.37 85.63
Air, Dry 0.00 0.02 75.51 23.18 1.29
our own experimental results.
In this simulation model the incident proton particles are targeted on a block homoge-
neous phantom with a depth of 45 cm, which is greater than the projected range of 220 MeV
protons in each of the materials. The source is 34.9 cm away from the surface of the target.
Both the source and phantom are staged in an environment filled with air. This MCNP6
model tracks the interactions resulting from the mono-energetic proton source that released
1*109 particles at 70, 160, 200 or 220 MeV respectively from a disk source, 1 cm radius,
uni-directionally towards the target, in the +z direction. This model neglects any energy
straggle or degradation of the incident protons due to generation or interaction with the
beam nozzle as they are released and any interactions structural or stabilization equipment
(e.g. couch) that would potentially interfere.
MCNP6 simulations for this work used the default Bertini internuclear cascade model,
the multi-step pre-equilibrium and evaporation model. The max energy for tracked protons
is set to 250 MeV and the Vavilov model for charged particle straggling is used rather
than continuous slowing-down approximation. The max energy for tracked neutrons is set
to 280 MeV and 10 MeV for photons. Coherent (Thompson) scattering is turned on but
the photoneuclear particle production is turned off (alternative is sampling one photon
interaction per collision). All neutron and proton nuclear interactions are processed and
delayed neutrons are treated as prompt. Doppler broadening was turned on and delayed
gammas are not generated.
The range of the incident proton beam is determined by tracking the change in proton
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Figure 9: Pulse-height image generated based on the MCNP6 FMESH tally to determined
flux of the incident proton providing an indication of particle range. The incident beam
energy from top to bottom: 220 MeV, 200 MeV, 160 MeV, 70 MeV. The target material
from left to right: PMMA, HPDE, Carbon. The images show that increased energy results
in increased depth and that changes slight changes to tissue composition and density in-
fluence the range of the incident particles. The fluence reported for each 0.1 mm grid was
determined with a relative statistical uncertainty of less than 0.008%
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Table 3: Incident proton range (cm), R80: The determined range values indicate the depth
at which the initial fluence drops by 50%. Values are reported in centimeters ±0.01cm.
Material Energy (MeV)
70 160 200 220
HPDE 4.01 17.45 25.49 29.60
PMMA 3.49 15.12 22.07 25.59
C 2.00 8.64 12.65 14.83
CaF 1.63 6.95 10.15 11.90
CaO 1.54 6.55 9.59 11.26
fluence along the beam path in 0.1 mm increments along the z-axis, with an FMESH4 tally.
These results are graphically expressed in the pulse-height images displayed in Fig. 9. The
incident beam energy from top to bottom: 220 MeV, 200 MeV, 160 MeV, 70 MeV. The
target material from left to right: PMMA, HPDE, carbon. The range is determined to be
the depth at which the proton fluence drops to 50% of its initial fluence, which corresponds
to 80% of the max dose point on a depth dose curve, R80. The proton range (R80) results
are tabulated in Tab. 3. The results shown in Fig. 9 were found to be in agreement when
compared with the expected range and lateral straggling predicted by SRIM 2013 data.
To further validate the range produced by the MC model, the range results are normal-
ized by their density and compared with the data available on Pstar for common elements
and compounds, carbon, PMMA, HDPE, and calcium fluoride, the relative statistical un-
certainty of the density normalized range (g/cm2) are all less then 1%. These results are in
agreement with the published values within 4%. They were also compared with the CSDA
range calculation to provide a reference in the absence of Pstar data. In this case the CSDA
range calculation based on the integration of Tmax to 0.1 MeV and the stopping power
was calculated based on composition and additive fractional composition, see Tab. 2. This
was done to provide a reference in the absence of Pstar data and to validate the use of
additive fractional composition for the use with compounds without established accepted
values currently available. The results are again in agreement within 4% and the results
are listed in Tab. 4. Having determined the normal behavior of the proton interactions in
this model the PG yield are evaluated.
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Table 4: Range comparison: The relative statistical uncertainty of the density normalized
range determined by MCNP is less than 0.007%. *Calculated values are in agreement within
5%.
Material T dt/dx Range (g/cm2) Pstar CSDA MCNP Range
(MeV) from Tmax to 0.1 MeV Range (g/cm
2) (g/cm2)
Hydrogen 70.00 1.92 1.91 N/A
Hydrogen 160.00 8.36 8.39 N/A
Hydrogen 200.00 12.30 12.38 N/A
Hydrogen 220.00 14.47 14.59 N/A
Carbon 70.00 4.60 4.58 4.51
Carbon 160.00 19.70 19.84 19.52
Carbon 200.00 28.85 29.17 28.58
Carbon 220.00 33.90 34.34 33.50
Oxygen 70.00 4.73 4.69 N/A
Oxygen 160.00 20.21 20.22 N/A
Oxygen 200.00 29.59 29.71 N/A
Oxygen 220.00 34.75 34.91 N/A
Calcium fluoide 70.00 5.15 5.27 5.17
Calcium fluoide 160.00 21.78 22.49 22.09
Calcium fluoide 200.00 31.81 32.96 32.26
Calcium fluoide 220.00 37.33 38.75 37.83
PMMA 70.00 4.03 4.19 4.11
PMMA 160.00 17.27 18.11 17.84
PMMA 200.00 25.30 26.67 26.04
PMMA 220.00 29.73 31.39 30.19
HDPE 70.00 3.7653 3.82 3.76
HDPE 160.00 16.20 16.60 16.40
HDPE 200.00 23.76 24.43 23.96
HDPE 220.00 27.92 28.76 27.82
Calcium oxide 70.00 5.09 N/A 5.14
Calcium oxide 160.00 21.49 N/A 21.93
Calcium oxide 200.00 31.38 N/A 32.11
Calcium oxide 220.00 36.82 N/A 37.70
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Table 5: Photon yield: values are reported as photons counted, from 0 to 10 MeV, per
source particle. The relative statistical uncertainty of the photon count measurements are
all less then 0.04%.
Material Energy (MeV)
70 160 200 220
C 0.00904 0.0396 0.0595 0.0707
PMMA 0.00972 0.0407 0.0598 0.0698
HPDE 0.00684 0.0300 0.0443 0.0518
CaO 0.0329 0.133 0.196 0.231
CaF2 0.0394 0.150 0.218 0.256
A cylindrical detector surface surrounds the target with a 40 cm diameter. The photon
particles were tracked with a surface tally as they crossed this surface in order to determine
the absolute yield of secondary prompt gammas produced from the proton interactions.
Tab. 5 tabulates the yield of gamma-ray from 0 to 10 MeV to cross the detector surface.
The statistical uncertainty of the photon count measurements are less then 0.04%. Fig. 10
compares this gamma-ray yield versus the normalized beam particle range for the materials
evaluated. Two distinct slope trends emerge, one for materials composed of oxygen, car-
bon, and hydrogen and another for those containing calcium. This suggests that the gross
gamma-ray yield alone does not provide enough information to independently indicate range
verification.
The photon energy data was also collected and the energy distribution was scored in
10 keV bins from 0 to 10 MeV, with a relative statistical uncertainty of less then 1% in all
bins with count rates greater than 10-6 photons per source particle. The resulting energy
spectra are used to compare the discreet peaks of oxygen, carbon and calcium at 6.1 MeV,
4.44 MeV, and 3.74 MeV, respectively, over various energies and chemical compositions.
We chose to primarily focus on these discrete energy peaks based on the consensus of
previous work indicating that the 6.1 MeV energy peak is a result of the 16O(p, x′γ6.18)
16O
and 16O(p, p′γ6.13)
16O nuclear reactions and that the 4.44 MeV energy peak results from
both the 16O(p, x′γ)12C and the 12C(p, p′γ)12C reaction. The 3.74 MeV energy peak is the
result of the 40Ca(p, p′γ)40Ca nuclear reaction with a 100% intensity while 40Ca is 96.94%
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Figure 10: Gross gamma-ray yield, from 0 to 10 MeV, versus the density normalized
beam particle range for the materials evaluated. Two distinct slope trends emerge, one
for materials composed of oxygen, carbon and hydrogen and another for those containing
calcium. This suggests that the gross gamma-ray yield alone does not provide enough
information to independently indicate range verification. The uncertainty of the photon
count measurements are all less then 0.03% and the range measurement (g/cm2) uncertainty
are less then 1%.
abundant (44Ca accounts for the majority of the remaining abundance and is not reported
to produce this discreet energy PG).
Fig. 11 shows the full photon energy spectrum simulated from 0 to 7.5 MeV and light
gray lines in the background highlight the energy range of interest. The results from carbon,
PMMA, and HDPE are shown in the first graph and calcium oxide, calcium fluoride, and
PMMA are shown in the second (the spectra are separated for improved viewing and PMMA
is shown on both for relative comparison). The middle and bottom plots of Fig. 11 zoom-in
on the regions of interest from 3 MeV to 7 MeV and 5 MeV to 7 MeV respectively showing
the calcium 3.74 MeV in calcium oxide and calcium fluoride on the right and its absence in
the carbon, PMMA, and HDPE spectrum.
The 3.74 MeV intensity plot, seen in Fig. 12, supports a linear correlation between
the 3.74 MeV peak intensity versus mass fraction of calcium by percentage. While J. Polf
has reported that the 4.44 MeV intensity correlated to the combined carbon and oxygen
composition in homogeneous targets of increasing sucrose concentrations, our results, seen
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Figure 11: MCNP6 energy spectrum resulting from the total photon yield. The results from
carbon, PMMA, and HDPE are shown on the left plot and calcium oxide, calcium fluoride,
and PMMA are shown on the right. The light gray lines in the background highlight the
energy range of interest at 6.13 MeV, 4.44 MeV, and 3.74 MeV. The photons are tallied in
10 keV bins with a statically relative uncertainty of less than 1% for all bins with count
rates greater than 10-6. Top: MCNP6 energy spectrum resulting from the total photon yield
from roughly 0 to 8 MeV. Middle: MCNP6 energy spectrum resulting from the total yield
of gamma-ray from roughly 3 to 7 MeV showing the calcium 3.74 MeV in calcium oxide and
calcium fluoride on the right and its absence in the carbon, PMMA, and HDPE spectrum.
Bottom: Energy spectrum resulting from the total yield of gamma-ray from roughly 3 to 7
MeV.
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Figure 12: Peak intensity (counts per source particle) versus mass fraction of target ma-
terial. This plot suggests a linear correlation between the 3.74 MeV peak intensity versus
the calcium mass fraction of each target.
in Fig. 13, are not as clear. [24] The results from the carbon, PMMA, and calcium oxide
trend toward a near linear correlation, however, the HDPE target data does not follow
this trend. Further, Fig. 13 shows a divergence of the peak intensity over the investigated
incident energy range. The three plots of Fig. 14 shows that our 6.13 MeV results do
indicate a peak that corresponds with the presence of oxygen, however the results do not
correspond well with the mass fraction of oxygen in our targets. They suggest that calcium
and fluorine may contribute to the total intensity calculated for this peak. However, since
fluorine accounts for less than 1% of human composition it may not significantly interfere
with interpretation for clinical applications and thus it may be appropriate to ignore this
contribution. Fluorine is reported to result in a PG of 6.13 MeV with an intensity of
56% from the following nuclear reactions according to the National Nuclear Data Center
(NNDC), 19F (p, p′)19F and 19F (p, x)19F . However NNDA does not report any 40Ca or
44Ca reaction resulting in a discreet 6.13 MeV peak.
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Figure 13: Peak intensity (counts per source particle) versus mass fraction of target mate-
rial. This plot shows the intensity of the 4.44 MeV peak versus the combined carbon and
oxygen mass fraction of each target. This shows a general agreement for the carbon, PMMA,
and the CaO target data but the HDPE does not fall in with a linear trend trend. Note,
this combined mass fraction summation does not account for the 4.44 MeV peak intensity
seen in the CaF2 is a result of interactions with fluorine. It may be appropriate to ignore
this ’contamination’ as fluorine accounts for less than 1% of the composition of the human
body, thus would not significantly interfere with interpretation for clinical applications.
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Figure 14: Peak intensity (counts per source particle) versus mass fraction of target ma-
terial. The first plot shows the intensity of the 6.13 MeV peak versus the mass fraction
of oxygen in each target. The mass fraction of oxygen alone does not account for the
relative 6.13 MeV peak intensities. The second plot shows the intensity of the 6.13 MeV
peak versus the combined oxygen and calcium mass fractions of each target. The third plot
shows the intensity of the 6.13 MeV peak versus the oxygen, calcium, and fluorine mass
fraction of each target. Of the targets evaluated in this study the best agreement is seen in
the third plot the oxygen, calcium, and fluorine mass fraction of each target however since
fluorine accounts for less than 1% of human composition it may not significantly interfere





The MC simulations are contingent on the availability and accuracy of the proton cross-
section data used which is limited in scope of material and incident energy thus limiting
the authenticity of the output energy spectrum produced. When the cross-section data
of interest is not available from tables, the simulation defaults to interpolation or general
physics models, thus producing different results. This divergence was seen in our preliminary
work when the material cards were coded with natural elements versus specific element
isotopes in naturally occurring ratios. In addition, previous publications and our preliminary
simulations indicated a tendency of MC simulations to under estimate the effects of Doppler
broadening in peaks of interest, particularly for carbon around the 4 MeV range. The
following experimental work was done to address these concerns and provide some means
of benchmarking to increase confidence in the MCNP MC results produced. Further these
results support the expectation that detection of PG in clinical environments at treatment
levels is possible.
4.1 Benchmark Experimental Design
In order to benchmark our MCNP simulation results, a series of experiments measuring
the PGs emitted from various targets composed of carbon, oxygen, and hydrogen were
performed. The resulting PG energy spectra ratios are then compared to those produced
by the MCNP simulations.
Northwestern Medicine Chicago Proton Center (CPC) is located 30 miles west of Chicago.
It houses an IBA 51230 cyclotron that supplies their proton beams. With this state-of-the-
art equipment they are able to offer treatment plans covering an energy range of roughly
70-220 MeV at snout of the beam nozzle. CPC also employs pencil beam scanning technol-
ogy that allows precise beam targeting [6].
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Figure 15: Left: Schematic illustration of experimental setup, not to scale. Right: Exper-
imental set-up at CPC. An IBA ST-230 cyclotron was used to generate a mono-energetic
proton beam at 220 MeV. A universal nozzle focuses and directs the incident pencil spot
beam onto the center of the identified target materials. The cerium-doped lanthanum(III)
bromide (LaBr3:Ce) detector and a HPGE were placed 475 mm from the center of the target
phantom at ninety degrees with respect to the incident beam axis. A lead brick collimator
with a 9 mm slit was placed 5 mm distal to detector surface to allow for location specific
assessment.
Experimental measurements were taken at CPC in order to evaluate MC simulations
produced by MCNP6. As shown in Fig. 15, an IBA ST-230 cyclotron was used to generate a
mono-energetic proton beam at 220 MeV. A universal nozzle focuses and directs the incident
pencil spot beam onto the center of the identified target materials (carbon, PMMA, and
HDPE). In order to measure the resulting PGs emitted, a cerium-doped lanthanum(III)
bromide (LaBr3:Ce) detector and a high purity geranium (HPGE) detector were placed 475
mm from the center of the target phantom at ninety degrees with respect to the incident
beam axis. A lead collimator with a 9 mm slit was placed 5 mm distal to detector surface
to allow for location specific assessment. Fig. 15 shows the experimental room set-up. The
220 MeV beam energy was run with a current of 180 nA. Each measurement was collected
for approximately 3840 MU over 5 minutes.
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4.1.0.1 Targets
In turn each target was positioned at the center of the couch within the beam-line and
the target depth of interest was aligned at beam iso-center for each measurement. Data
collection was initiated at the depth just beyond the anticipated Bragg peak deposition for
each target material. The couch was translated in 10 mm increments along the beamline
in order to shift the desired target depth to the measurement point. The 2.5 x 2.5 x 40
cm3 PMMA blocks were provided. The HDPE sample, from Argonne National Laboratory
in Chicago, is 2.5 inches in diameter and 21 inches long. 4 x 4 x 20 in3 graphite blocks
composed of carbon was sourced from Georgia Institute of Technology.
4.1.0.2 Detectors
LaBr3:Ce (LaBr) detector was used to measure the emitted photon spectra. The detector is
a medium-resolution scintillation detector comprised of a 1.5 cm x 1.5 cm LaBr crystal and
a photomultiplier tube (PMT) with an internal magnetic shield manufactured by Canberra.
This detector was chosen for its high energy resolution compared to other scintillators, and
improved linearity and efficiency with short decay times (16 ns) relative to NaI(TI) crystals
[25, 5].
A second HPGE detector was also used to collect the emitted photon spectra. This de-
tector is a high-resolution semi-conductor diode manufactured by Canberra. These detectors
are well accepted for their excellent energy resolution, particularly for photons, allowing for
the resolution of tightly packed peaks that remain unresolved in most scintillation detectors
currently available.
4.1.1 Energy Calibration
The facility did not have any calibration check sources available in the anticipated region
of interest between 2-10 MeV. As a result, the energy calibration is based on check source
measurements performed with the same equipment and settings at Georgia Institute of
Technology. The points used include Co-60 (1332.5 keV, 1173.2 keV), Cs-137 (662 keV),
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PuBe (4438.9 keV, 3927.9 keV, 3416.9 keV), and Th (583.1 keV (Ti-208), 911.1 keV (Ac-
228), 969.1 keV (Ac-228), and 2614 keV (Ti-208)), as well as the internal decay signature
of the LaBr3:Ce detector at 1436 keV. The calibration curves were then confirmed through
verification of the internal LaBr decay signature and naturally occurring thorium decay
products in the background experimental measurements as well as the annihilation peak at
0.511 MeV in beam-on experimental measurements.
4.1.2 Background Radiation
The background spectrum was evaluated to verify that remaining background or activa-
tion from earlier clinical treatments were not at a statistically significant level that would
interfere with the data collection. Due to limited room-time and beam-time, individual
background measurements were not taken between each run, however, a ten minute back-
ground of the target was taken at the end of the beam-time to quantify the activation of
the target as well as a ten minute background with the target removed from the beam line.
4.1.3 Experimental Data
LaBr3:Ce data was acquired for the carbon, PMMA, and HDPE targets. Unfortunately,
these data did not provide any useful insight or method validation due to the limited energy
resolution and constrained energy calibration. The HPGE detector was used to collect data
for the PMMA target and, as would be expected, provided improved energy resolution
allowing for the identification and quantification of several regions of interest. Fig. 16
shows the full cumulative spectra collected on a log-scale. The 6.1 MeV peak and its single
and double escape peak, at 5.6 MeV and 5.1 MeV can already be identified.
After the post-beam-time background was subtracted to remove activation background
from the spectrum a ROOT subtraction was applied. This was done in order to further
improve the resolution by removing some of the continuous energy data. Fig. 17 shows
a section of the spectrum with various iteration levels that could be removed via this
subtraction method. Ten iterations were used for the following plots as it was the best
fit for the energy range of interest for 2 MeV to 8 MeV.
Fig. 18 shows the PMMA cumulative energy spectra from 4.5 MeV to 7.5 MeV collected
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Figure 16: PMMA cumulative energy spectra from 0 MeV to 9 MeV collected with an
HPGE detector.
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Figure 17: ROOT subtraction method applied to improve resolution. The 10 iterations
line was selected as the best fit for the energy range of interest.
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Figure 18: PMMA cumulative energy spectra from 4.5 MeV to 7.5 MeV collected with
an HPGE detector. (1a) 6.1 MeV peak, (1b) single escape peak 5.6 Mev and (1c) double
escape peak 5.1 MeV. The 7.1 Mev from oxygen and its single escape peak is also labeled,
(2a) and (2b) respectively.
with an HPGE detector. The 6.13 MeV integrated area is highlighted in red and the full
energy peak integral is equal to 928 counts over 16 bins. The single and double escape peak
integrals result in 1163 counts and 804 counts respectively over 16 bins each. The 7.1 Mev
from oxygen and its single escape peak is also labeled, (2a) and (2b) respectively. Fig. 19
highlights the 4.44 MeV and 6.13 MeV peaks and their corresponding double and single
escape peaks after the data was re-binned. The 4.44 MeV integrated area is high-lighted
in green. The full energy peak integral is equal to 268 counts over 6 bins. The single and
double escape peak integrals result in 393 counts over bin 6 bins and 363 counts over 4 bins
respectively.
4.1.4 Data Evaluation
The results generated by the MCNP models are idealized data sets resulting in sharp clean
peaks relative to the obtainable experimental results. There are a number of factors that
contribute to this effect. The MC models are able to track each particle history, counting
every flagged photon that crosses the identified surface of interest representing the detector,
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Figure 19: HPGE PMMA cumulative Energy spectra from 3.5 MeV to 7.5 MeV ROOT
re-binned for improved resolution around the 4 MeV range. The (2a) 4.44 MeV peak, (2b)
single escape peak 3.9 MeV and (2c) double escape peak 3.4 MeV labeled and integrated
area is highlighted in green. The (1a) 6.1 MeV peak, (1b) single escape peak 5.6 Mev and
(1c) double escape peak 5.1 MeV labeled and integrated area is highlighted in red.
thus providing the equivalent of 100% detection efficiency. Unfortunately, this efficiency rate
is not possible in application. Experimental data are limited by the detector‘s ability to
“convert the kinetic energy of charged particles in light” and “the light into an electrical
pulse” [11] as well as the decay time of the induced luminescence of the scintillation crystal.
Further, the MC model is counting photon flux, which is essentially equivalent to as-
suming 100% energy deposition, thus we see less Compton scatter in our simulation spectra
as well as an absence of single and double escape peaks. In reality this is one of the primary
challenges faced by detectors, particularly at this energy range. Here they are attempting
to balance the need for a thick enough detector to allow full energy deposition while still
being thin enough to allow the signal to reach the PMT.
The particle flux rate experienced in a clinical setting is very fast, on the order of
5 ∗ 109/cm2/s. This creates challenges for current detectors. The high flux rate results in
new signals activating the scintillation crystal before the induced luminescence from the
previous signal has had adequate time to decay. This is known as pulse pile-up and results
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in detector dead-time due to its inability to process additional signals until the induced
luminescence drops below its threshold. This efficiency limitation effectively limits the
available counting statistics within each run at such high flux rates. This is particularly
true of detectors with a high energy resolution. This does not hinder the MCNP MC models
as they do not take time into consideration and flux rates are effectively simplified to fluence
for the purpose of simulations.
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Figure 20: HPGE PMMA cumulative Energy spectra from 3 MeV to 7 MeV ROOT re-
binned for improved resolution around the 4 MeV range. The full energy deposition peak,
(1a), and the single, (1b), and double, (1c), escape peaks for the 6.13 MeV peak are high-
lighted in red; the full energy deposition peak, (2a), and the single, (2b), and double, (2c),
escape peaks for the 4.44 MeV peak are highlighted in green; the full energy deposition
peak, (2a), and the single escape peak, (2b), for the 7.12 MeV peak are highlighted in
blue. The double escape peak is not distinctly visible as it is buried within the full energy
deposition peak of 6.13 MeV.
4.2 Verification with MNCP6 Model
In an effort to show agreement between the results generated from MCNP6 and our exper-
imental evaluation the peak intensity ratios for the 6.13 MeV and 7.12 MeV are compared.
The full energy deposition peak, (1a), and the single, (1b), and double, (1c), escape peaks
for the 6.13 MeV peak are highlighted in red the full energy deposition peak, (2a), and the
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Table 6: Integration of peaks highlighted in Fig. 20. * Indicates calculated counts.
Energyγ Peak Peak integral
(MeV) label (counts)
4.44 3a 268± 16
3b 393± 20
3c 363± 19
6.13 1a 728± 48*
1b 1163± 34
1c 804± 28
7.12 2a 170± 13
2b 333± 18
(2c) 200± 18*
single escape peak, (2b), for the 7.12 MeV peak are highlighted in blue in Fig. 20. The 7.12
MeV double escape peak is not distinctly visible as it is buried within the full energy deposi-
tion peak of 6.13 MeV. As a result, the area under the peaks could not be simply integrated,
summed and compared. Instead the single escape peak for each energy was integrated and
normalized by the germanium pair production in nuclear field cross section. The resulting
intensity ratio of the 7.12 Mev to 6.13 MeV peak intensity, 0.248 ± 0.02, was found to be
in good agreement with that produced by our simulation, 0.262 ± 0.002. This result is in
agreement within 5.4%. These results are shown in Tab. 7. Making the assumption that
the single escape and double escape ratio is the same, the 7.12 MeV double escape peak
could be calculated and separated from the full energy deposition of the 6.13 MeV peak.
The resulting measured counts are listed in Tab. 6. This allowed for the summation of the
count contribution from each energy, which was then normalized by the germanium total
cross section. The resulting intensity ratio of the 7.12 Mev to 6.13 MeV peak intensity,
0.261 ± 0.03, was found to be in good agreement with that produced by our simulation,
0.262± 0.002 as shown in Tab. 8. This result is in agreement within 0.2%
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Table 7: Evaluation of 6.13 MeV and 7.12 MeV double escape peak ratio from experimental
data and MCNP6 simulation. This result is in agreement within 5.4%.
Photon S.E. Ge P.P. nuc Integral MC Peak 1:2 Peak 1:2
Energy Integral cross-section Norm Intensity ratio ratio
(MeV) (counts) (cm2/g) (photons/s.p) experimental MCNP
4.44 394 0.008027 49046 0.00822
6.13 1162 0.01164 99871 0.000235
7.12 333 0.01341 24847 0.0000615 0.24± 0.02 0.26± 0.002
Table 8: Evaluation of 6.13 MeV and 7.12 MeV detection ratio from experimental data
(summing counts from full energy deposition, and single and double escape peaks) and
MCNP6 simulation. This result is in agreement within 0.2%.
Photon Sum Ge total Integral MC Peak 1:2 Peak 1:2
Energy Integral cross-section Norm Intensity ratio ratio
(MeV) (counts) (cm2/g) (photons/s.p) experimental MCNP
4.44 1024 0.03217 31839 0.00822
6.13 2694 0.03104 86822 0.000235
7.12 703 0.03095 22727 0.0000615 0.26± 0.03 0.26± 0.002
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CHAPTER V
DISCUSSION OF SOURCES OF UNCERTAINTY
5.1 Source of Uncertainty in Proton Therapy
The application of the distinct therapeutic advantages of proton therapy are currently lim-
ited due to the relatively large overall uncertainty in dose delivery. A number of contributing
factors including, but not limited to, uncertainty due to imaging, patient setup and motion,
beam delivery, dose calculation and approximations, material constants, CT conversions,
and biological effects [19]. The current method of managing these uncertainties is to in-
corporate larger treatment margins to ensure tumor coverage. Current standard practice
is an increased treatment margin of 2.5%+1.5mm to 3.5%+3mm [19], which is designed to
compensate for 1% patient set-up, up to 2% for I-values and ∼ 4% for tissue densities.
5.1.0.1 Range Measurement
Ideally particle range would be defined at 80% of max dose. This is the point at which 50%
of protons have stopped for a mono-energetic beam and this point is relatively independent
of the beams energy distribution. However, for historical reasons, since photons and electron
range is measured at 90% maximum dose, proton range is clinically measured at 90% of
maximum dose [20].
5.1.0.2 Tissue Composition
Particle range is dependent on the electron density and the atomic fraction of the medium(s)
the particle travels through. This calculation is relatively straight forward when the par-
ticle is traveling through homogeneous material; however, this becomes more complicated
to compute as the particle travels through multiple layers of heterogeneous materials and
similar materials composed of varying tissue compositions. The human body is made up of
several different tissue types and organ size is patient specific. Thus size and composition
should be determined on an individual basis for the region of interest. Slight variations
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in tissue composition can also occur, especially for oxygen concentration between healthy
and unhealthy tissue regions. Since patient specific organ size and exact tissue composi-
tion is difficult to determine directly, this information is currently determined indirectly
through some form of imaging. As a result, these indirect measurements and conversions
add additional uncertainty to the range calculation.
5.1.0.3 Mean Ionization Energy
Another important variable in determining stopping power, based on Bethe-Bloch formula,
is the mean excitation energy, which is an empirically determined value. Previous research
by Andreo et al. [1] has shown that there are significant uncertainties in the mean excitation
energy, I-value, due to tissue composition and particle energies thus ‘ICRU-44 recommends
that body tissue not be treated as a physical constant.’ “It was concluded that the range
uncertainty due to uncertainties in I-values is on the order of ±1.5 − 2.0%. The difference
in I-value between 75 and 80 eV results in a 0.8− 1.2% difference in the predicted stopping
power in the therapeutic energy range.” [1]
5.2 Uncertainty in Monte Carlo calculations
There are several components that contribute to the uncertainty associated with the MC re-
sults produced by the MCNP code including statistical sampling, interaction cross-sections,
geometry, and source signal.
5.2.1 Statistical
The code provides an internal evaluation of ten statistical tests to provide users with an
indication of how well (precise) the tally converges on the final answer. This does not
provide the user with any indication of the accuracy of the result but rather that all of the
histories sampled converge toward a consistent result. If a simulation fails to pass any of
the tests, adjustments should be made to rectify the discrepancy, such as increasing the
number of histories run.
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5.2.2 Cross-section
The particle cross-sections indicate the probability of particle interaction. The code obtains
this information from large tabulated data sets, known as libraries, for various particle types,
energies, materials (for limited elements and isotopes), and limited temperature and density
options. Only one library containing proton cross-sections is currently available for MCNP6,
which includes information for a total of 48 elements. The cross-section uncertainty values
(probability distribution) for this published data set is not currently available.
5.2.3 Geometry
The geometry of the environment, including the physical dimensions of cells, material den-
sities, and material composition also contribute to the uncertainty of the calculated results.
This could be evaluated with the PERT card which randomly varies the input and produces
two outputs (with and without the variation). In this simulation this was not performed as
it was assumed to be accurate within detectable limits.
5.2.4 Calculation of source and detector signal
There are also uncertainties associated with changes in starting energies of source particles.
This takes place due to degradation of the incident energy and divergence resulting from
interactions with the nozzle or other components of the accelerator. This is often difficult
to simulate due to lack of or limited knowledge of exact ‘nozzle’ design due to limits on the
the information provided by manufacturers. This could be investigated with the use of the
ISO spectra modifier, however, this was ignored in this simulation as it was performed with
a mono-energetic beam.
5.3 Quantification of Experimental Uncertainty
5.3.1 Systematic physics uncertainties
Systematic physics uncertainties includes consistent or fundamental errors introduced to an
experimental system based on equipment or experimental design. This is when the same
error consistently influences every measurement the same way resulting in all of the data
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collected being recorded over or under the true measurement in a consistent direction. Mul-
tiple data collection equipment or measurement methods may needed in order to determine
if this type of error is introduced into the system since the error is fundamental in the setup.
Steps that may have introduced systematic physics uncertainties into the experimental
system discussed here include but are not limited to: normalization with respect to the
number of ions, MU measurement system of the treatment system, background subtraction
procedure, and the geometrical description of each setup including the detector field of view
and the solid angle.
5.3.2 Statistical physics uncertainties
Statistical physics uncertainties are random error within the system. As with computational
measurements it is important to collect enough data points with a large enough signal to
provide a normalized distribution around the true value. This component of uncertainty is
calculated by propagating the variance of each of the individual system components through
a function relating these components to the measured results of the system and reporting the





The gross yield of secondary PG from a proton beam at clinically relevant energies of 70,
160, 200, and 220 MeV would not provide a direct indication of an unknown target‘s RSP.
However, the data gravitates towards two distinct slope trends, one for materials composed
of carbon and hydrogen and another for those containing calcium. This is likely due to
larger proton absorption cross section of calcium. This indicates that this information
may be more useful in conjunction with other potentially known variables about the target
composition to provide range verification.
The 3.74 MeV energy peak that results from the 40Ca(p, p′γ)40Ca nuclear reaction
shows a linear correlation with calcium composition of the targets. Based on the materials
evaluated, the 4.44 MeV peak from 16O(p, x′γ)12C and 12C(p, p′γ)12C and the 6.13 MeV
peak expected from 16O(p, p′γ)16O nuclear reactions do not appear unique to the carbon
and oxygen inelastic decay. These peaks may still be useful if further studied show that
other primary materials in the human body do not contribute significantly to these discrete
energies. Otherwise these peaks may require a more sophisticated algorithm that could
incorporate composition information from unique peaks to resolve the relative contribution
from peaks that result from the summation of multiple reactions.
The experimental work performed to further validate the MC model showed a good
agreement between the relative peak ratio determined from experimental data with model
prediction. The peak intensity of the 6.13 MeV and 7.12 MeV peaks from oxygen were
compared as they were both distinctly identifiable in both data sets and both result from
PGs emitted from proton interactions with oxygen. The results indicated that the single





Experimental studies are very important for future work to provide a means of validation
and bench-marking as it is still rather early in the development of this subject matter.
Further evaluation of absolute PG yield and gross energy spectra produced from targets
composed of the primary elements found in the human body is needed. Of particular interest
would be data from materials containing calcium. Additional spectrum from a broader
variation of oxygen and carbon material compositions would continue to be beneficial but it
is important to be cognizant that the primary peaks being investigated for these materials
may not be unique enough to provide a complete picture.
6.2.2 Computational
While it is important to continue experimental work to provide validation and bench-
marking of the production of secondary PG and to improve the cross-section data available,
it is still useful to pursue computational evaluations to explore and optimize these tech-
niques for range verification. This is especially true due to the limitation in time, cost,
and access to proton beam-time. Evaluation of targets containing various concentrations
of calcium as well as concentrations of elements commonly found in the human body other
than carbon, oxygen, and hydrogen should be investigated to validate that the discrete en-
ergy peaks of interest, such as 3.74 MeV for calcium, are unique to the element of interest.
It would be useful to determine an algorithm to resolve contributions from the continuum
resulting from heavier elements, such as calcium, from oxygen contributions to the 6.13
MeV and 7.12 MeV peaks or identify an alternate unique peak corresponding to oxygen.
In conjunction, improved correlation between PG intensity and elemental composition may
be resolved by comparing cross-section and threshold energy of the peaks of interest for
their impact on count intensity for peaks resulting from multiple contributions. In addi-
tion it would be valuable to perform sensitivity analysis due to its dependency on available
cross-section data/physics models to evaluate the confidence of this work. As a next step,
heterogeneous targets could be evaluated to determine if these correlations hold and that
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it is still possible to resolve the characteristic peaks of interest.
Finally, further MC simulated energy spectra should be measured at location specific
depths parallel to the beam path and compared with corresponding experimental data. The
location specific gross PG yield could provide range verification and the energy spectrum
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